Nova Eye Medical Limited

OTCPK:ELXM.F Stock Report

Market Cap: US$30.7m

Nova Eye Medical Past Earnings Performance

Past criteria checks 0/6

Nova Eye Medical's earnings have been declining at an average annual rate of -9.3%, while the Medical Equipment industry saw earnings growing at 9.1% annually. Revenues have been declining at an average rate of 42.4% per year.

Key information

-9.3%

Earnings growth rate

-7.7%

EPS growth rate

Medical Equipment Industry Growth8.9%
Revenue growth rate-42.4%
Return on equity-44.4%
Net Margin-72.4%
Last Earnings Update31 Dec 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Nova Eye Medical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:ELXM.F Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2215-11210
30 Sep 2214-9190
30 Jun 2213-7170
31 Mar 2213-7170
31 Dec 2113-6150
30 Sep 2113-5140
30 Jun 2113-4130
31 Dec 2012-9120
30 Sep 2013-10130
30 Jun 2013-10140
31 Dec 1916-6160
30 Sep 1916-6170
30 Jun 1916-7180
31 Mar 1948-7341
31 Dec 1849-6341
30 Sep 1864-6371
30 Jun 1879-5411
31 Mar 1877-5361
31 Dec 1775-5321
30 Sep 1773-3311
30 Jun 1772-1291
31 Mar 17721281
31 Dec 16733271
30 Sep 16733261
30 Jun 16733261
31 Mar 16703241
31 Dec 15672221
30 Sep 15652221
30 Jun 15632211
31 Mar 15611201
31 Dec 14591191
30 Sep 14571181
30 Jun 14541171
31 Mar 14510161
31 Dec 1347-1151
30 Sep 1345-1151
30 Jun 1343-1141
31 Mar 13430140
31 Dec 12430150
30 Sep 12451150

Quality Earnings: ELXM.F is currently unprofitable.

Growing Profit Margin: ELXM.F is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ELXM.F is unprofitable, and losses have increased over the past 5 years at a rate of 9.3% per year.

Accelerating Growth: Unable to compare ELXM.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: ELXM.F is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (3.7%).


Return on Equity

High ROE: ELXM.F has a negative Return on Equity (-44.36%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.